Buchumschlag

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Muneto Tatsumoto, Miki Ishida, Katsuhiro Iba, Byung‐Kun Kim, Xiaoping Ning, Chihiro Osawa, Masami Nakai, Yuka Kurita
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Headache: The Journal of Head and Face Pain
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
von: Nathaniel M. Schuster, et al.
Veröffentlicht: (2025)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
von: Shuu‐Jiun Wang, et al.
Veröffentlicht: (2024)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
von: Jeffrey D. Sharon, et al.
Veröffentlicht: (2024)

Cost per treatment responder analysis of atogepant compared to rimegepant for the preventive treatment of episodic migraine
von: Jessica Ailani, et al.
Veröffentlicht: (2024)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
von: Richard B. Lipton, et al.
Veröffentlicht: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
von: Graham A. McLeod, et al.
Veröffentlicht: (2025)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
von: Ghader Mohammadnezhad, et al.
Veröffentlicht: (2024)

Habitual caffeinated beverage consumption and headaches among adults with episodic migraine: A prospective cohort study
von: Maggie R. Mittleman, et al.
Veröffentlicht: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
von: Rikki Mangrum, et al.
Veröffentlicht: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
von: Yunus Emre Meydanal, et al.
Veröffentlicht: (2025)

Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions
von: Janosch Fox, et al.
Veröffentlicht: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
von: Emmanuelle A. D. Schindler, et al.
Veröffentlicht: (2025)

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real‐life multicenter study
von: Julia Peris‐Subiza, et al.
Veröffentlicht: (2025)

Patient satisfaction with calcitonin gene‐related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study
von: Alba López‐Bravo, et al.
Veröffentlicht: (2025)

Evaluating associations of migraine‐related vertigo
von: Nazia Karsan, et al.
Veröffentlicht: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
von: Koichi Ikeda, et al.
Veröffentlicht: (2025)

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study
von: Gabriel Paiva da Silva Lima, et al.
Veröffentlicht: (2025)

Afterimage duration differs for migraine with or without aura
von: Florian Rimmele, et al.
Veröffentlicht: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
von: Rebecca Erwin Wells, et al.
Veröffentlicht: (2024)

Useful considerations for treating migraine in patients with autism
von: Sinifunanya E. Nwaobi
Veröffentlicht: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
von: Gabriel Camargo de Oliveira, et al.
Veröffentlicht: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
von: Inga Zalia Tummoszeit, et al.
Veröffentlicht: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
von: Chia‐Chun Chiang, et al.
Veröffentlicht: (2024)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
von: Charly Gaul, et al.
Veröffentlicht: (2025)

Counting the cost: How migraine shapes lives and economies
von: Risako Shirane, et al.
Veröffentlicht: (2025)

Cardiovascular risk and triptan usage among patients with migraine
von: Ido Peles, et al.
Veröffentlicht: (2025)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
von: Amy A. Gelfand
Veröffentlicht: (2024)

Cognitive and emotional mechanisms underlying migraine quality of life
von: Shiri Shinan‐Altman, et al.
Veröffentlicht: (2026)

Integrating gepants into clinical practice for the acute treatment of migraine
von: Richard B. Lipton, et al.
Veröffentlicht: (2026)

A retrospective analysis of the use of candesartan for migraine prevention in adolescents
von: Irene Patniyot, et al.
Veröffentlicht: (2024)

Chronotype in migraine and tension‐type headache: A population study
von: Da Eun Jung, et al.
Veröffentlicht: (2026)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
von: Raghavan Gopalakrishnan, et al.
Veröffentlicht: (2024)

Causal associations between genetically predicted placental weight and migraine
von: Chung‐Chih Liao, et al.
Veröffentlicht: (2025)

Time to reconsider the association between migraine and white matter hyperintensities?
von: Anders Hougaard
Veröffentlicht: (2025)

Investigating the causal and genetic relationship between migraine and Parkinson's disease
von: Ming‐Gang Deng, et al.
Veröffentlicht: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
von: Bilal Ahmed Rizvi, et al.
Veröffentlicht: (2024)

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
von: Susan Hutchinson, et al.
Veröffentlicht: (2026)

The role of stress in the comorbidity of migraine and other chronic primary pain
von: Shi‐Jie Zhao, et al.
Veröffentlicht: (2025)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
von: Antonio Munafò, et al.
Veröffentlicht: (2026)

Prevalence and burden of migraine in the United States: A systematic review
von: Fred Cohen, et al.
Veröffentlicht: (2024)